🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Effects of Mirror Therapy on Lower Extremity in CP Children

RecruitingNAAges 6 Years - 12 YearsAllRiphah International University
NCT06673823 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

A non-progressive condition that harms the developing brain both during and after birth is cerebral palsy (CP). It is a multifaceted syndrome marked by abnormalities in movement and posture, along with concomitant sensory-motor, cognitive, and behavioral impairments and seizures. CP can be divided into three types based on neurological classification: spastic, athetoid, and ataxic, impairments in motor skills and posture are hallmarks of cerebral palsy. Various strategies have been employed in motor skill improvement interventions. One of them, mirror-mediated treatment, works by stimulating mirror neurons in a specific region of the brain cortex. Mirror-mediated therapy involves the patient observing movement of his or her own limb reflected in a mirror, which activates mirror neurons. The application of mirror treatment improved gait capacity by elevating physical perception and balanc

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Age 6-12 years. * Motor tone of effected lower extremity is 1 to 2 according to modified Ashworth scale. * Patient with enough cognition to understand and follow instructions Exclusion Criteria: * Patients with any other neurological illness affecting their lower extremities (e.g., MS, Parkinson's, peripheral neuropathy). * Patients with prior fractures of the lower limb (ankle or foot). * Patients with other forms of musculoskeletal diseases such as severe arthritis, ankle surgery, leg length difference.
💊

What it tests

  • Mirror therapy
  • conventional therapy
📍

Where

1 site
Riphah International University
Lahore, Pakistan
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy